Amgen announced that the Arthritis Advisory Committee of the U.S. FDA will review data supporting the Company's Biologics License Application...
Read moreEisai Co Ltd. announced that interim analyses on the latest data for the world's first anti-fractalkine monoclonal antibody E6011, discovered...
Read moreMerck in partnership with Pfizer Inc. announced that two Phase 3 studies (VERTIS Mono and VERTIS Factorial) of ertugliflozin, an...
Read moreThe US CPSC, which is tasked with protecting children and families from risks of injuries or death associated with consumer...
Read moreIndianapolis-based pharmaceutical giant Eli Lilly LLY -0.64% laid out an ambitious R&D agenda for launching up to 20 new drugs...
Read moreFinal Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival...
Read moreAbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and...
Read moreAlmac Group, the global contract development and manufacturing organisation, is pleased to announce an expansion to its serialisation capabilities to...
Read moreMerck, known as MSD outside the United States and Canada, announced that the U.S. FDA has granted Breakthrough Therapy Designation...
Read more
Will Represent Sixth U.S. Patent to Be Listed in the Orange Book for RAVICTI Horizon Pharma plc (NASDAQ: HZNP), a...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
